Conjugated hepcidin mimetics
US12234300B2 · kind B2 · utility
0Cited by
28References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 7, 2023 |
| Grant date | Feb 25, 2025 |
| Priority date | — |
| Expiry date | Aug 7, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides hepcidin analogues with improved in vivo half lives, and related pharmaceutical compositions and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.